Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine and Spaced iTBS for Motor Plasticity
NCT05081986Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Aug 2021
- Primary completion
- Oct 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in major depressive disorder (MDD), sponsored by University of Calgary. Started Aug 2021; status: completed.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05081986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05081986.